Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-25-026414
Filing Date
2025-12-05
Accepted
2025-12-05 16:52:53
Documents
1
Period of Report
2025-12-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A formdef14a.htm DEF 14A 200517
  Complete submission text file 0001493152-25-026414.txt   201861
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-12555 | Film No.: 251553611
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)